BioCentury
ARTICLE | Clinical News

FDA approves US WorldMeds' Lucemyra for opioid withdrawal

May 18, 2018 2:31 AM UTC

FDA approved Lucemyra lofexidine from US WorldMeds LLC (Louisville, Ky.) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. According to the agency, Lucemyra is the first non-opioid drug approved by FDA to manage opioid withdrawal symptoms.

US WorldMeds did not respond to inquiries regarding its launch plans or pricing details...